Literature reference · Respiratory Medicine
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics.
PubMed · Retrieved 2026-10-13
Bibliographic record: ERJ open research (2024 Jul). PMID 39040578. DOI 10.1183/23120541.00151-2024.
Reference details
- Authors
- James D Chalmers; Pierre-Régis Burgel; Charles L Daley; Anthony De Soyza; Charles S Haworth; David Mauger; Kevin Mange; Ariel Teper; Carlos Fernandez; Dan Conroy; Mark Metersky
- Journal
- ERJ open research
- Publication date
- 2024 Jul
- PMID
- 39040578
- DOI
- 10.1183/23120541.00151-2024
- Volume
- 10
- Issue
- 4
- Language
- eng
- Publication types
- Journal Article
Citation
James D Chalmers; Pierre-Régis Burgel; Charles L Daley; Anthony De Soyza; Charles S Haworth; David Mauger; Kevin Mange; Ariel Teper; Carlos Fernandez; Dan Conroy; Mark Metersky. Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristics.. ERJ open research. 2024 Jul.
Access and reuse
This page presents bibliographic facts and links from the PubMed record. The publisher abstract and full article are not reproduced. Follow the source links to read the research and check its current status.
Sources and reuse
- PubMed record
- Publisher DOI
- PMC article (check reuse terms)
- Bibliographic metadata; article text excluded
Bibliographic or product metadata. Read the original source for the complete document.
Source date: 2024-07-31. Retrieved: 2026-10-13. Text has been organized for reading; this import has not been independently reviewed by a clinician. It is not individualized medical advice.